Precision BioSciences Inc (DTIL)
8.28
-0.11
(-1.31%)
USD |
NASDAQ |
Nov 12, 15:12
Precision BioSciences Revenue (Annual): 48.73M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 48.73M |
December 31, 2022 | 25.10M |
December 31, 2021 | 115.53M |
December 31, 2020 | 24.28M |
Date | Value |
---|---|
December 31, 2019 | 22.24M |
December 31, 2018 | 10.88M |
December 31, 2017 | 6.484M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
22.24M
Minimum
2019
115.53M
Maximum
2021
47.18M
Average
25.10M
Median
2022
Revenue (Annual) Benchmarks
Assembly Biosciences Inc | 7.163M |
TG Therapeutics Inc | 233.66M |
Protagonist Therapeutics Inc | 60.00M |
Alector Inc | 97.06M |
Entrada Therapeutics Inc | 129.01M |